These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34135202)

  • 1. A Single-Arm Open-Label Clinical Trial on the Efficacy and Safety of Sirolimus for Epileptic Seizures Associated with Focal Cortical Dysplasia Type II: A Study Protocol.
    Kada A; Tohyama J; Shiraishi H; Takahashi Y; Nakagawa E; Akiyama T; Saito AM; Inoue Y; Kato M
    Kurume Med J; 2021 Jul; 66(2):115-120. PubMed ID: 34135202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus for epileptic seizures associated with focal cortical dysplasia type II.
    Kato M; Kada A; Shiraishi H; Tohyama J; Nakagawa E; Takahashi Y; Akiyama T; Kakita A; Miyake N; Fujita A; Saito AM; Inoue Y
    Ann Clin Transl Neurol; 2022 Feb; 9(2):181-192. PubMed ID: 35040598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sirolimus for epileptic seizures in childhood associated with focal cortical dysplasia type II.
    Shiraishi H; Teramoto T; Yokoshiki S; Tohyama J; Ueda Y; Egawa K; Sato N; Manabe A; Kato M
    Brain Dev; 2023 Jun; 45(6):343-347. PubMed ID: 36870920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR-therapy and targeted treatment opportunities in mTOR-related epilepsies associated with cortical malformations.
    Auvin S; Baulac S
    Rev Neurol (Paris); 2023 Apr; 179(4):337-344. PubMed ID: 36906459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term seizure outcome in 211 patients with focal cortical dysplasia.
    Fauser S; Essang C; Altenmüller DM; Staack AM; Steinhoff BJ; Strobl K; Bast T; Schubert-Bast S; Stephani U; Wiegand G; Prinz M; Brandt A; Zentner J; Schulze-Bonhage A
    Epilepsia; 2015 Jan; 56(1):66-76. PubMed ID: 25495786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement.
    Hsieh LS; Wen JH; Claycomb K; Huang Y; Harrsch FA; Naegele JR; Hyder F; Buchanan GF; Bordey A
    Nat Commun; 2016 Jun; 7():11753. PubMed ID: 27249187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
    Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH
    Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal seizures versus epileptic spasms in children with focal cortical dysplasia and epilepsy onset in the first year.
    Serino D; Freri E; Ragona F; D'Incerti L; Bernardi B; Di Ciommo V; Granata T; Vigevano F; Fusco L
    Epilepsy Res; 2015 Jan; 109():203-9. PubMed ID: 25524860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic variants in diverse genes leads to a spectrum of focal cortical malformations.
    Lai D; Gade M; Yang E; Koh HY; Lu J; Walley NM; Buckley AF; Sands TT; Akman CI; Mikati MA; McKhann GM; Goldman JE; Canoll P; Alexander AL; Park KL; Von Allmen GK; Rodziyevska O; Bhattacharjee MB; Lidov HGW; Vogel H; Grant GA; Porter BE; Poduri AH; Crino PB; Heinzen EL
    Brain; 2022 Aug; 145(8):2704-2720. PubMed ID: 35441233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
    Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial omics reveals molecular changes in focal cortical dysplasia type II.
    Vermeulen I; Rodriguez-Alvarez N; François L; Viot D; Poosti F; Aronica E; Dedeurwaerdere S; Barton P; Cillero-Pastor B; Heeren RMA
    Neurobiol Dis; 2024 Jun; 195():106491. PubMed ID: 38575092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
    Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH
    Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal Cortical Dysplasia and Refractory Epilepsy: Role of Multimodality Imaging and Outcome of Surgery.
    Jayalakshmi S; Nanda SK; Vooturi S; Vadapalli R; Sudhakar P; Madigubba S; Panigrahi M
    AJNR Am J Neuroradiol; 2019 May; 40(5):892-898. PubMed ID: 31000525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development.
    Jeong A; Wong M
    J Child Neurol; 2018 Jan; 33(1):55-63. PubMed ID: 29246093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal cortical dysplasia pathology: diagnostic difficulty, classification, and utility for pathogenesis.
    Kapar O; Gurkan ZM; Dolgun M; Sencer A; Gürses C; Bilgic B
    Neurosurg Focus; 2022 Oct; 53(4):E6. PubMed ID: 36183176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of focal cortical dysplasia type Ib atypically showing reversible intensity changes on magnetic resonance imaging which could be affected by epileptic discharge activity.
    Kuroda N; Fujimoto A; Enoki H; Arai Y; Okanishi T
    Childs Nerv Syst; 2019 May; 35(5):883-887. PubMed ID: 30810857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal cortical dysplasia links to sleep-related epilepsy in symptomatic focal epilepsy.
    Wang Y; He C; Chen C; Wang Z; Ming W; Qiu J; Ying M; Chen W; Jin B; Li H; Ding M; Wang S
    Epilepsy Behav; 2022 Feb; 127():108507. PubMed ID: 34968776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain somatic mutations in MTOR leading to focal cortical dysplasia.
    Lim JS; Lee JH
    BMB Rep; 2016 Feb; 49(2):71-2. PubMed ID: 26779999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
    Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
    Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant adenosine signaling in patients with focal cortical dysplasia.
    Guo M; Zhang J; Wang J; Wang X; Gao Q; Tang C; Deng J; Xiong Z; Kong X; Guan Y; Zhou J; Boison D; Luan G; Li T
    Mol Neurobiol; 2023 Aug; 60(8):4396-4417. PubMed ID: 37103687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.